RejuvaHeart™ Technology As A Component of the RejuvaFlow Program
Cleared and indicated for use even in advanced angina patients (regardless having already undergone surgical intervention) the RejuvaHeart device provides a mechanical modality that delivers counter pulsation through gentle air compression of the patient’s lower extremities while they relax comfortably on a special bed.
This technique has been clinically proven in double blind, placebo trials to dramatically increase arterial blood flow in peripheral and coronary arteries- with well documented primary and secondary health benefits to the treatment recipeients. With hundreds of published studies supporting a broad range of treatment benefits, some notable study highlights complementing the RejuvaFlow treatment program include:
-Counterpulsation as a New Treatment Modality for Patients with Erectile Dysfunction.
Froschermaier, S, Urology Int 1998;61:168-171
Patients with erectile dysfunction who received therapy with this non-invasive mechanical modality for one hour per day showed a significant improvement in penile rigidity after completion of a twenty treatment course. Approximately 71% of patients who were completely unable to have penetrative sexual intercourse (SI) before treatment, reported satisfactory SI was possible after treatment. Study patients also underwent Doppler sonography. Post treatment results showed a measurable and significant improvement of penile peak systolic flow with no adverse effects observed. In the written opinion of the study authors, this mechanical modality “…offers a simple and noninvasive treatment for ED of predominantly vascular origin”.
-Effect of External Counterpulsation on Medically Refractory Angina Patients with Erectile Dysfunction.
Lawson, et.al, Int J Clin Pract 2007;61:757-762
A comparison of pre and post therapy with this mechanical modality demonstrated a significant improvement in erectile function, intercourse satisfaction and overall satisfaction. A clear increase is seen in the proportion of patients with no symptoms of ED, as well as a concomitant decrease in the proportion with severe ED, post mechanical therapy. This data also supports that the working mechanism of action for this local mechanical therapy can remain effective in even end-stage CAD patients by mediating an improvement in vascular function and associated ED.
-Enhanced External Counterpulsation in Patients with Coronary Artery Disease-Associated Erectile Dysfunction.
Part 1 El-Sakka, J,J Sex Med 2007;4:771-779
Because the pathological processes of ED are similar to those involved in many vascular diseases, this study focused on 44 male patients with severe diffuse triple vessels disease to assess the effect of risk factors on the efficacy and satisfaction rate of this mechanical modality in patients with ED associated with coronary artery disease. While the presence of some risk factors negatively influenced efficacy and satisfaction, there was a significant post treatment improvement in erectile function. In total, 79.5% of patients in the study were overall satisfied regarding both angina and sexual function improvement.
-Effect of External Counterpulsation on Nitric Oxide Production In Coronary Disease.
Qian X-X, Wu W- , Sheng et al. J Heart Dis 1999;1:193
This mechanical modality can have systemic effects mediated by increases in nitric oxide levels that persist beyond the immediate course of therapy and are associated with normalization of endothelial function as assessed by reactive hyperaemia-peripheral artery tonometry. By increasing nitric oxide production, this therapy potentially augments penile arterial vasodilation and may enhance erections.
-Pneumatic Counterpulsation: A New Method to Improve Organ Perfusion.
Werner, D, The American Journal of Cardiology 1999;84:950-52
As regards the aging process, medical science today points to inflammation as the “cause” of aging. Werners’s study measured the effect of this mechanical modality on nloodflow to different organ systems using Doppler ultrasound. Each treatment showed increased blood flow everywhere from the heart to the brain, liver and even kidneys. Thirty five (35) treatment sessions with this modality also decreased circulating levels of proinflammatory biomarkers in patients studied.
Given what we know about free radical tissue damage in diseased states, the antioxidant effect of increasing oxygen supply to aging organs highlight the ability of this treatment modality to improve blood flow in general.
(Excerpts taken directly from each study cited)